Eradicate Hepatitis C Virus: A pilot of treatment as prevention in active drug users

Trial Profile

Eradicate Hepatitis C Virus: A pilot of treatment as prevention in active drug users

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 May 2017

At a glance

  • Drugs Simeprevir (Primary) ; Telaprevir (Primary) ; Peginterferon alfa; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms Eradicate HCV; ERADICATE Hep C; Eradicate-C
  • Most Recent Events

    • 08 May 2017 Status changed from recruiting to completed.
    • 21 Jun 2016 Planned End Date changed from 31 Aug 2015 to 31 Aug 2017.
    • 24 Feb 2016 Planned number of patients changed from 100 to 200 as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top